Evolent Health (EVH) Other financing activities (2015 - 2024)

Evolent Health has reported Other financing activities for 10 years, with the latest figure at -$1000.0 in Q4 2024.

• On a quarterly basis, Other financing activities fell 100.03% year-over-year to -$1000.0 in Q4 2024; TTM through Sep 2025 was -$1000.0, a 100.01% decrease from a year earlier, with the FY2024 full-year figure at $3.5 million, down 72.35% from the prior year.
• Other financing activities was -$1000.0 for Q4 2024 at Evolent Health, down from $2.3 million in the prior quarter.
• The five-year high for Other financing activities was $6.5 million in Q1 2021, with the low at -$1000.0 in Q4 2024.
• Average Other financing activities over 5 years is $1.9 million, with a median of $1.6 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2024: Other financing activities soared 7659.52% in 2021, then tumbled 100.03% in 2024.
• Over 5 years, Other financing activities stood at $603000.0 in 2020, then jumped by 185.74% to $1.7 million in 2021, then tumbled by 31.98% to $1.2 million in 2022, then jumped by 184.64% to $3.3 million in 2023, then tumbled by 100.03% to -$1000.0 in 2024.
• The last three Other financing activities figures came in at -$1000.0 (Q4 2024), $2.3 million (Q3 2024), and $61000.0 (Q2 2024), per Business Quant data.